Pseudo-Parkinson disease secondary to ritonavir-buspirone interactionCLAY, Patrick G; ADAMS, Molly M.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 202-205, issn 1060-0280, 4 p.Article

Stability assay of buspirone hydrochloride in tabletsCARDOSO, S. G; SCHAPOVAL, E. E.Pharmazie. 1998, Vol 53, Num 5, pp 349-351, issn 0031-7144Article

Synthesis of the anxiolytic agent (¹⁴C) 6-hydroxy-buspirone for use in a human ADME studyBONACORSI, Samuel J; BURRELL, Richard C; LUKE, George M et al.Journal of labelled compounds & radiopharmaceuticals. 2007, Vol 50, Num 1-2, pp 65-71, issn 0362-4803, 7 p.Article

The effect of buspirone on normal and hypoarousal-driven abnormal aggression in ratsHALLER, Jozsef; HORVATH, Zsuzsanna; BAKOS, Nikoletta et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 1, pp 27-31, issn 0278-5846, 5 p.Article

Apneusis responding to buspirone in multiple sclerosisO'SULLIVAN, R. J; BROWN, I. G; PENDER, M. P et al.Multiple sclerosis. 2008, Vol 14, Num 5, pp 705-707, issn 1352-4585, 3 p.Article

High-performance liquid chromatography-tandem mass spectrometry with a new quadrupole/linear ion trap instrumentHAGER, James W; LE BLANC, J. C.Journal of chromatography. 2003, Vol 1020, Num 1, pp 3-9, issn 0021-9673, 7 p.Conference Paper

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophyHEO, Jae-Hyeok; LEE, Soon-Tae; CHU, Kon et al.Journal of the neurological sciences. 2008, Vol 271, Num 1-2, pp 87-90, issn 0022-510X, 4 p.Article

Treatment of spinocerebellar ataxia with buspironeASSADI, Mitra; CAMPELLONE, Joseph V; JANSON, Christopher G et al.Journal of the neurological sciences. 2007, Vol 260, Num 1-2, pp 143-146, issn 0022-510X, 4 p.Article

Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspironeLAINE, Kari; AHOKOSKI, Outi; HUUPPONEN, Risto et al.European journal of clinical pharmacology. 2003, Vol 59, Num 10, pp 761-766, issn 0031-6970, 6 p.Article

Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with BuspironeLEGGIO, Gian Marco; CAMILLIERI, Giovanni; BUCOLO, Claudio et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 8, pp 2017-2028, issn 0893-133X, 12 p.Article

Non-nicotine pharmacotherapy for smoking cessation : Mechanisms and prospectsBENOWITZ, N. L; PENG, M. W.CNS drugs. 2000, Vol 13, Num 4, pp 265-285, issn 1172-7047Article

Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitorsJARONCZYK, Małgorzata; WOLOSEWICZ, Karol; CHILMONCZYK, Zdzisław et al.European journal of medicinal chemistry. 2012, Vol 49, pp 200-210, issn 0223-5234, 11 p.Article

Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorderCUBALA, Wiesław Jerzy; LANDOWSKI, Jerzy.Journal of affective disorders. 2014, Vol 152-154, pp 468-473, issn 0165-0327, 6 p.Article

Attenuation of apomorphine-induced sensitization by buspironeIKRAM, Huma; DARAKHSHAN JABEEN HALEEM.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 3, pp 444-450, issn 0091-3057, 7 p.Article

Co-administration of fluoxetine and WAY100635 improves short-term memory functionFERNANDEZ-PEREZ, Sabela; PACHE, David M; SEWELL, Robert D. E et al.European journal of pharmacology. 2005, Vol 522, Num 1-3, pp 78-83, issn 0014-2999, 6 p.Article

Effect of the 5HT_1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar ratSIVARAO, Digavalli V; NEWBERRY, Kimberly; LODGE, Nicholas J et al.European journal of pharmacology. 2004, Vol 494, Num 1, pp 23-29, issn 0014-2999, 7 p.Article

Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortexLIU, Y. P; WILKINSON, L. S; ROBBINS, T. W et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 175-185, issn 0033-3158, 11 p.Article

Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tabletsTAKKA, Sevgi; SAKR, Adel; GOLDBERG, Arthur et al.Journal of controlled release. 2003, Vol 88, Num 1, pp 147-157, issn 0168-3659, 11 p.Article

BUSPAR^® (buspirone): 1er représentant d'une nouvelle famille d'anxiolytiques: symposiums nationaux, Paris, 25 novembre et 3 décembre 1988 = BUSPAR^® (buspirone): first representative of a new family of anxiolytics: National Symposiums, Paris, the 25th and 3rd december 1988FERRERI, M.Psychologie médicale. 1989, Vol 21, issn 0048-5756, 7-82 [76 p.], spec. BConference Proceedings

Acute, but not repeated, administration of the neurotensin NTS₁ receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in ratsPRUS, Adam J; HILLHOUSE, Todd M; LACROSSE, Amber L et al.Progress in neuro-psychopharmacology & biological psychiatry. 2014, Vol 49, pp 78-84, issn 0278-5846, 7 p.Article

Different MK-801 administration schedules induce mild to severe learning impairments in an operant conditioning task: Role of buspirone and risperidone in ameliorating these cognitive deficitsRAPANELLI, Maximiliano; FRICK, Luciana Romina; BERNARDEZ-VIDAL, Micaela et al.Behavioural brain research. 2013, Vol 257, pp 156-165, issn 0166-4328, 10 p.Article

Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxietyBENCAN, Zachary; SLEDGE, Damiyon; LEVIN, Edward D et al.Pharmacology, biochemistry and behavior. 2009, Vol 94, Num 1, pp 75-80, issn 0091-3057, 6 p.Article

Modulation of buspirone HC1 release from hypromellose matrices using chitosan succinate : Implications for pH-independent releaseALKHATIB, Hatim S; AIEDEH, Khaled M; BUSTANJI, Yasser et al.European journal of pharmaceutics and biopharmaceutics. 2008, Vol 70, Num 3, pp 804-812, issn 0939-6411, 9 p.Article

Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampusWISLOWSKA-STANEK, Aleksandra; ZIENOWICZ, Malgorzata; LEHNER, Malgorzata et al.Neuroscience letters. 2005, Vol 389, Num 2, pp 115-120, issn 0304-3940, 6 p.Article

Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancersMEIDAN, Victor M; AL-KHALILI, Mohammad; MICHNIAK, Bozena B et al.International journal of pharmaceutics. 2003, Vol 264, Num 1-2, pp 73-83, issn 0378-5173, 11 p.Article